Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer Diagnostics says it is back in the game with a new generation of laboratory products

This article was originally published in Clinica

Executive Summary

Bayer is developing a new range of diagnostic products, which it says will bring flexibility and cost-savings to labs, as well as developing a secure revenue stream for the company. New self-testing procedures are also slated as important growth products, reports Martin Hedges, who went to Tarrytown, New York, to see Bayer Diagnostics at work.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts